DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Anti-Infective AgentsAnti-Infective Agents
  5. /Antibacterial AgentsAntibacterial Agents
  6. /ReltecimodReltecimod
Chemical structure of CAS 1447799-33-8

Reltecimod

CAS No.1447799-33-8
MDL No.N/A
MFC46H72N10O15S
MW1037.20
InChI KeyVRNHFZYMPDKTBS-WYUJEMNCSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1447799-33-8
Product NameReltecimod

Associated Conditions

infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI): Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod (AB 103).

Annals of surgery • Vol. 272, Issue 3 • 2020
PMID: 32657946DOI: 10.1097/SLA.0000000000004102

A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial.

JAMA surgery • Vol. 149, Issue 6 • 2014
PMID: 24740134DOI: 10.1001/jamasurg.2013.4841

A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.

The Journal of infectious diseases • Vol. 207, Issue 12 • 2013
PMID: 23493729PMC: PMC3654752DOI: 10.1093/infdis/jit104

Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.

PLoS biology • Vol. 9, Issue 9 • 2011
PMID: 21931534PMC: PMC3172200DOI: 10.1371/journal.pbio.1001149

Documentation

Similar Products

  • FAM49B (190-198) mouse

    CAS No.1588388-60-6

  • Disomotide

    CAS No.181477-43-0

  • MAGE-3 Peptide

    CAS No.154652-68-3

  • GPR110 peptide agonist P12

    CAS No.1778685-49-6

  • Proctolin

    CAS No.57966-42-4

  • Angiotensin II acetate

    CAS No.68521-88-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact